Voluntis Strengthens Its Global Customer Support Services in Collaboration With Zendesk Highly personalized support provided for patients and healthcare professionals using Voluntis' digital therapeutics Improved scalability of Voluntis' operations by supporting the commercial rollout of the growing number of solutions co-developed with life sciences partners in new geographies Regulatory News: Voluntis (Paris:ALVTX) (Euronext Growth Paris, Ticker: ALVTX ISIN: FR0004183960) a leader in digital therapeutics, today announces the upgrade of its global customer support infrastructure in collaboration with customer service software company Zendesk. Thanks to the new collaboration, Voluntis will leverage Zendesk's capabilities to integrate and streamline the support services it provides for its pharma partners as part of the commercialization of co-developed digital therapeutics and in full compliance with applicable regulations.